Akari Therapeutics PLC (AKTX) — SC 13D/A Filings
All SC 13D/A filings from Akari Therapeutics PLC. Browse 2 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (2)
-
Patel Amends Akari Therapeutics Stake Filing
— Dec 6, 2024 Risk: medium
Samir Rashmikant Patel filed an amendment (No. 1) to Schedule 13D on November 14, 2024, regarding Akari Therapeutics Plc. This filing indicates a change in the -
RPC Pharma Ltd Amends Akari Therapeutics Stake
— Jun 20, 2024 Risk: medium
On June 20, 2024, RPC Pharma Ltd, acting as trustee for the Sonic Healthcare Holding Co, filed an amendment (Amendment No. 8) to its Schedule 13D for Akari Ther
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX